NONOF - Regeneron eyes Wegovy combo to improve quality of weight loss
2024-01-10 12:09:02 ET
More on Regeneron Pharmaceuticals
- Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript)
- Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade)
- Regeneron Pharmaceuticals Inc. (REGN) American Society of Hematology 2023 Investor Conference - (Transcript)
- Regeneron to post over $1.3B U.S. Eylea sales in Q4
- Alvotech rises as biosimilar to Regeneron’s Eylea succeeds in clinical trial
For further details see:
Regeneron eyes Wegovy combo to improve quality of weight loss